Jundishapur Journal of Microbiology

Published by: Kowsar

Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes

Hatice Uludag Altun 1 , * , Server Yagci 1 , Cemal Bulut 1 , Hunkar Sahin 2 , Sami Kinikli 1 , Ali Kudret Adiloglu 2 and Ali Pekcan Demiroz 1
Authors Information
1 Department of Infectious Diseases and Clinical Microbiology Clinic, Ankara Training and Research Hospital, Ankara, Turkey
2 Department of Medical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey
Article information
  • Jundishapur Journal of Microbiology: December 01, 2014, 7 (12); e13347
  • Published Online: December 1, 2014
  • Article Type: Research Article
  • Received: July 4, 2013
  • Revised: September 21, 2013
  • Accepted: October 14, 2013
  • DOI: 10.5812/jjm.13347

To Cite: Altun H U, Yagci S, Bulut C, Sahin H, Kinikli S, et al. Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes, Jundishapur J Microbiol. 2014 ; 7(12):e13347. doi: 10.5812/jjm.13347.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Larsen AR. Infectious Disease. 1989; : 35-40
  • 2. Ferrara AM. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents. 2006; 27(3): 183-95[DOI][PubMed]
  • 3. Akalın, H.. Hastane infeksiyonları. 2003; : 269-87
  • 4. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2004; 48(5): 1586-92[PubMed]
  • 5. Bello H, Dominguez M, Gonzalez G, Zemelman R, Mella S, Young HK, et al. In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998. J Antimicrob Chemother. 2000; 45(5): 712-3[PubMed]
  • 6. Rodriguez-Hernandez MJ, Cuberos L, Pichardo C, Caballero FJ, Moreno I, Jimenez-Mejias ME, et al. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J Antimicrob Chemother. 2001; 47(4): 479-82[PubMed]
  • 7. Fontana C, Favaro M, Minelli S, Bossa MC, Testore GP, Leonardis F, et al. Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect Dis. 2008; 8: 79[DOI][PubMed]
  • 8. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007; 59(4): 772-4[DOI][PubMed]
  • 9. Clinical and Laboratory Standards Institute . Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A9. 2010;
  • 10. Chuang YC, Sheng WH, Lauderdale TL, Li SY, Wang JT, Chen YC, et al. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J Microbiol Immunol Infect. 2014; 47(4): 324-32[DOI][PubMed]
  • 11. Olive DM, Bean P. Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol. 1999; 37(6): 1661-9[PubMed]
  • 12. Carretto E, Barbarini D, Farina C, Grosini A, Nicoletti P, Manso E, et al. Use of the DiversiLab semiautomated repetitive-sequence-based polymerase chain reaction for epidemiologic analysis on Acinetobacter baumannii isolates in different Italian hospitals. Diagn Microbiol Infect Dis. 2008; 60(1): 1-7[DOI][PubMed]
  • 13. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis. 2002; 34(11): 1425-30[DOI][PubMed]
  • 14. Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1998; 42(6): 793-802[PubMed]
  • 15. Joly-Guillou ML, Wolff M, Farinotti R, Bryskier A, Carbon C. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. J Antimicrob Chemother. 2000; 46(5): 827-30[PubMed]
  • 16. Ruiz J, Nunez ML, Perez J, Simarro E, Martinez-Campos L, Gomez J. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis. 1999; 18(4): 292-5[PubMed]
  • 17. Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol. 2006; 44(4): 423-31[PubMed]
  • 18. Yavuz MT, Şahin, İ. , Behçet, M. , Öztürk, E. , Kaya, D. . Antibiotic Susceptibility of Acinetobacter baumannii Strains Isolated from Various Clinical Samples. ANKEM. 2006; 20(2): 107-710
  • 19. Ozdem B, Gurelik FC, Celikbilek N, Balikci H, Acikgoz ZC. [Antibiotic resistance profiles of Acinetobacter species isolated from several clinical samples between 2007-2010]. Mikrobiyol Bul. 2011; 45(3): 526-34[PubMed]
  • 20. Turk Dagi H, Arslan U, Tuncer I. Antibiotic Resistance of Acinetobacter baumannii Strains Isolated from Blood Cultures. ANKEM Dergisi. 2011; 25(1): 27-30[DOI]
  • 21. Alp E, Esel D, Yildiz O, Voss A, Melchers W, Doganay M. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Scand J Infect Dis. 2006; 38(5): 335-40[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments